These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 28405139)

  • 1. Regulation of intestinal permeability: The role of proteases.
    Van Spaendonk H; Ceuleers H; Witters L; Patteet E; Joossens J; Augustyns K; Lambeir AM; De Meester I; De Man JG; De Winter BY
    World J Gastroenterol; 2017 Mar; 23(12):2106-2123. PubMed ID: 28405139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens.
    Awad WA; Hess C; Hess M
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28208612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor signaling in intestinal permeability regulation.
    Pontarollo G; Mann A; Brandão I; Malinarich F; Schöpf M; Reinhardt C
    FEBS J; 2020 Feb; 287(4):645-658. PubMed ID: 31495063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of disease: protease functions in intestinal mucosal pathobiology.
    Antalis TM; Shea-Donohue T; Vogel SN; Sears C; Fasano A
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jul; 4(7):393-402. PubMed ID: 17607295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteases and small intestinal barrier function in health and disease.
    Giuffrida P; Biancheri P; MacDonald TT
    Curr Opin Gastroenterol; 2014 Mar; 30(2):147-53. PubMed ID: 24445329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine proteases decrease intestinal epithelial ion permeability by activation of protein kinase Czeta.
    Swystun VA; Renaux B; Moreau F; Wen S; Peplowski MA; Hollenberg MD; MacNaughton WK
    Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G60-70. PubMed ID: 19460843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tight junctions: from molecules to gastrointestinal diseases.
    Moonwiriyakit A; Pathomthongtaweechai N; Steinhagen PR; Chantawichitwong P; Satianrapapong W; Pongkorpsakol P
    Tissue Barriers; 2023 Apr; 11(2):2077620. PubMed ID: 35621376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases.
    Ceuleers H; Van Spaendonk H; Hanning N; Heirbaut J; Lambeir AM; Joossens J; Augustyns K; De Man JG; De Meester I; De Winter BY
    World J Gastroenterol; 2016 Dec; 22(47):10275-10286. PubMed ID: 28058009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal Proteases from Pouchitis Patients Activate Protease Activating Receptor-2 to Disrupt the Epithelial Barrier.
    Hoffman S; Aviv Cohen N; Carroll IM; Tulchinsky H; Borovok I; Dotan I; Maharshak N
    J Crohns Colitis; 2019 Dec; 13(12):1558-1568. PubMed ID: 31056700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway.
    Yan H; Ajuwon KM
    PLoS One; 2017; 12(6):e0179586. PubMed ID: 28654658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal permeability--a new target for disease prevention and therapy.
    Bischoff SC; Barbara G; Buurman W; Ockhuizen T; Schulzke JD; Serino M; Tilg H; Watson A; Wells JM
    BMC Gastroenterol; 2014 Nov; 14():189. PubMed ID: 25407511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition.
    Willemsen LE; Hoetjes JP; van Deventer SJ; van Tol EA
    Clin Exp Immunol; 2005 Nov; 142(2):275-84. PubMed ID: 16232214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. They Must Hold Tight: Junction Proteins, Microbiota And Immunity In Intestinal Mucosa.
    Castoldi A; Favero de Aguiar C; Moraes-Vieira PM; Olsen Saraiva Câmara N
    Curr Protein Pept Sci; 2015; 16(7):655-71. PubMed ID: 26122786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intestinal epithelial barrier: a therapeutic target?
    Odenwald MA; Turner JR
    Nat Rev Gastroenterol Hepatol; 2017 Jan; 14(1):9-21. PubMed ID: 27848962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions.
    Catalioto RM; Maggi CA; Giuliani S
    Curr Med Chem; 2011; 18(3):398-426. PubMed ID: 21143118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of intestinal epithelial permeability by tight junctions.
    Suzuki T
    Cell Mol Life Sci; 2013 Feb; 70(4):631-59. PubMed ID: 22782113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of epithelial cells in initiation and propagation of intestinal inflammation. Eliminating the static: tight junction dynamics exposed.
    Shen L; Turner JR
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G577-82. PubMed ID: 16537969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.
    Carroll IM; Maharshak N
    World J Gastroenterol; 2013; 19(43):7531-43. PubMed ID: 24431894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptor 2 and gut permeability: a review.
    Bueno L; Fioramonti J
    Neurogastroenterol Motil; 2008 Jun; 20(6):580-7. PubMed ID: 18482083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease activated receptor 2: a new target for IBS treatment.
    Bueno L
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():95-102. PubMed ID: 18924448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.